Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy.

Cui SZ, Lei ZY, Guan TP, Fan LL, Li YQ, Geng XY, Fu DX, Jiang HW, Xu SH

Open source

DOI
10.1111/cas.14375
Published
2020 May
Container
Cancer science
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cas.14375,
  title = {Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy.},
  author = {Cui SZ and Lei ZY and Guan TP and Fan LL and Li YQ and Geng XY and Fu DX and Jiang HW and Xu SH},
  year = {2020},
  journal = {Cancer science},
  doi = {10.1111/cas.14375},
  url = {https://doi.org/10.1111/cas.14375}
}

RIS

TY  - JOUR
TI  - Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy.
AU  - Cui SZ
AU  - Lei ZY
AU  - Guan TP
AU  - Fan LL
AU  - Li YQ
AU  - Geng XY
AU  - Fu DX
AU  - Jiang HW
AU  - Xu SH
PY  - 2020
JO  - Cancer science
DO  - 10.1111/cas.14375
UR  - https://doi.org/10.1111/cas.14375
ER  - 

APA

SZ, C., ZY, L., TP, G., LL, F., YQ, L., XY, G., DX, F., HW, J., & SH, X. (2020). Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy.. Cancer science. https://doi.org/10.1111/cas.14375

Source records